Hydrochlorothiazid Léčiva (Hydrochlorothiazide)

Hydrochlorothiazid Léčiva is prescribed for several cardiovascular and renal indications. It is commonly used to manage:

• Hypertension (high blood pressure) as part of a broader treatment plan.
• Edema associated with congestive heart failure.
• Fluid retention due to liver cirrhosis.
• Edema related to chronic kidney disease.
• Adjunct therapy for resistant hypertension when combined with other antihypertensives.

• Hydrochlorothiazide inhibits the Na+/Cl- symporter located in the distal convoluted tubule of the nephron. By blocking this transporter, the drug reduces sodium and chloride reabsorption, leading to increased urinary excretion of sodium, chloride, and water. The resulting reduction in extracellular fluid volume decreases venous return and cardiac output, contributing to lower systemic blood pressure and alleviation of fluid overload.

Hydrochlorothiazid Léčiva may cause a range of adverse reactions, from mild to severe. Patients should be aware of both common and serious possibilities.

Common

• Increased frequency of urination.
• Low potassium levels (hypokalemia).
• Dizziness or light‑headedness.
• Headache.
• Fatigue.
• Elevated blood glucose.

Serious

• Severe dehydration.
• Marked electrolyte disturbances (e.g., hyponatremia, hypokalemia).
• Acute gout attacks.
• Pancreatitis.
• Allergic reactions such as rash or angioedema.
• Blood dyscrasias (e.g., leukopenia, thrombocytopenia).

Before starting Hydrochlorothiazid Léčiva, certain health considerations should be reviewed. Important precautions include:

• Assess renal function; dose adjustment may be needed in impaired kidneys.
• Monitor serum electrolytes, especially potassium and sodium, during therapy.
• Use cautiously in patients with a history of gout, as uric acid levels may rise.
• Observe blood glucose closely in diabetic patients.
• Evaluate risks versus benefits in pregnancy; safety data are limited.
• Elderly patients may be more susceptible to orthostatic hypotension.
• Consider liver disease status, as fluid shifts can affect dosing.

Hydrochlorothiazid Léčiva can interact with several medication classes, influencing efficacy or safety. Interaction guidance includes:

Avoid

• Lithium, due to increased lithium toxicity.
• NSAIDs, which may reduce diuretic effectiveness and impair renal function.
• Digoxin, as electrolyte shifts can predispose to toxicity.
• Corticosteroids, which may exacerbate fluid retention and potassium loss.

Use with caution

• Other antihypertensive agents, to avoid excessive blood pressure reduction.
• Additional diuretics, which can increase the risk of dehydration and electrolyte imbalance.
• Antidiabetic drugs, because hypokalemia may affect glucose control.
• Antihistamines, which may enhance drowsiness or dizziness.